Compare IOVA & ASTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IOVA | ASTH |
|---|---|---|
| Founded | 2007 | 1994 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 996.1M |
| IPO Year | 2008 | 2015 |
| Metric | IOVA | ASTH |
|---|---|---|
| Price | $3.53 | $19.82 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 12 | 9 |
| Target Price | $10.45 | ★ $40.78 |
| AVG Volume (30 Days) | ★ 9.3M | 567.4K |
| Earning Date | 05-25-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 32.28 | N/A |
| EPS | N/A | ★ 0.33 |
| Revenue | N/A | ★ $519,907,752.00 |
| Revenue This Year | $60.04 | $58.46 |
| Revenue Next Year | $58.54 | $25.22 |
| P/E Ratio | ★ N/A | $60.48 |
| Revenue Growth | N/A | ★ 45.90 |
| 52 Week Low | $1.64 | $18.08 |
| 52 Week High | $5.64 | $36.20 |
| Indicator | IOVA | ASTH |
|---|---|---|
| Relative Strength Index (RSI) | 77.86 | 38.64 |
| Support Level | $2.11 | $18.08 |
| Resistance Level | $3.73 | $23.94 |
| Average True Range (ATR) | 0.19 | 1.12 |
| MACD | 0.09 | 0.10 |
| Stochastic Oscillator | 97.56 | 32.71 |
Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.
Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. The company's three reportable segments are Care Partners, Care Delivery, and Care Enablement. It generates the majority of its revenue from the Care Partners segment.